Qi Ma

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Brain Metastases

Renal Cell Carcinoma

Top Venues

Therapeutic advances in medical oncology

OncoTargets and therapy

Oxidative medicine and cellular longevity

Journal of clinical laboratory analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Fei, Jia-Wei Xue, Ji-Zhongrong Wu, Chong-Yi Yang, Ke-Jie Wang, Qi Ma
Promising therapy for neuroendocrine prostate cancer: current status and future directions. Therapeutic advances in medical oncology 16 (2024)
Xin Fei, Jia-Wei Xue, Ji-Zhongrong Wu, Chong-Yi Yang, Ke-Jie Wang, Qi Ma
Promising therapy for neuroendocrine prostate cancer: current status and future directions. Therapeutic advances in medical oncology 16 (2024)
Kai-Yun Wang, Ke-Jie Wang, Qi Ma
The expression and significance of p4E-BP1/4E-BP1 in prostate cancer. Journal of clinical laboratory analysis 36 (4) (2022)
Jian-Zhou Cao, Jin-Feng Pan, Derry Mingyao Ng, Meng-Qi Ying, Jun-Hui Jiang, Qi Ma
Maintenance Long-Term Multiple Cycles Treatment with Docetaxel in Metastatic Castration-Resistant Prostate Cancer: A Report of Three Cases. OncoTargets and therapy 14 (2021)
Ke-Jie Wang, Xiang-Yu Meng, Jun-Feng Chen, Kai-Yun Wang, Cheng Zhou, Rui Yu, Qi Ma
Emodin Induced Necroptosis and Inhibited Glycolysis in the Renal Cancer Cells by Enhancing ROS. Oxidative medicine and cellular longevity 2021 (2021)